At a Glance
| Harmala alkaloid | 1cP-LSD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Routes | oral | |
| Effects | 7 documented | 77 documented |
| Interaction | Caution | |
Harmala alkaloid, a Psychedelic, and 1cP-LSD, a Psychedelic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Psychedelics, meaning they share a common pharmacological foundation. They share 4 documented effects in common, with 3 effects unique to Harmala alkaloid and 73 unique to 1cP-LSD. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Harmala alkaloid | 1cP-LSD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Routes | oral | |
| Effects | 7 documented | 77 documented |
| Interaction | Caution | |
| Level | Dose |
|---|---|
| Threshold | 15 µg |
| Light | 25–75 µg |
| Common | 75–150 µg |
| Strong | 150–300 µg |
| Heavy | 300 µg |
MAOIs dramatically potentiate psychedelics; drastically reduce dose and exercise extreme caution
No dangerous interactions recorded.